Learn / IMCR
NASDAQ: IMCR
Immunocore Holdings plc (IMCR) stock, explained like you're 5
Immunocore Holdings plc trades on the Nasdaq under the ticker IMCR. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 1.5 billion dollars.
- Ticker
- IMCR
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Small cap, about 1.5 billion dollars
Is Immunocore Holdings plc a small, medium or large cap company?
No. Immunocore Holdings plc is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.5 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Immunocore Holdings plc makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves IMCR stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Immunocore Holdings plc (IMCR) stock price, news, quote and history (Yahoo Finance UK)
- Insulin making cells are just 1% of the pancreas. Immunocore has dosed its first patient in a trial to protect them. (Stock Titan)
- (IMCR) Volatility Zones as Tactical Triggers (Stock Traders Daily)
- Immunocore Holdings plc (IMCR) stock price, news, quote and history (Yahoo Finance Singapore)
- Immunocore (IMCR) Stock May Trade Above Fair Value On A 48% Slump (Simply Wall Street)
Follow IMCR in your daily brief
Each trading day at 5 PM ET we post what happened to Immunocore Holdings plc and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow IMCR
Questions about Immunocore Holdings plc stock
What does Immunocore Holdings plc do?
Immunocore Holdings plc trades on the Nasdaq under the ticker IMCR. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 1.5 billion dollars.
What is the ticker symbol for Immunocore Holdings plc?
Immunocore Holdings plc trades under the ticker IMCR on the Nasdaq.
What is Immunocore Holdings plc's market cap?
Immunocore Holdings plc is a small cap stock with a market cap of about 1.5 billion dollars.
How does Immunocore Holdings plc make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves IMCR stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow IMCR stock every day?
Add IMCR to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.